The Combitest® screen is a prenatal test that lets you know whether you are at risk of carrying a fetus affected by one of the most common birth defects: Trisomy 21, Trisomy 18, Trisomy 13, Spina Bifida and Anencephaly. When the Combitest® screen is performed in the first trimester (between 11 weeks and 3 days to 13 weeks and 6 days of pregnancy), it consists of taking a blood sample for analysis and performing a nuchal translucency ultrasound. In the second trimester (between 14 weeks to 17 weeks and 6 days of pregnancy), the Combitest® screen requires only that a blood sample be taken for a blood test.

The Combitest® screen does not pose any danger to the mother or to the fetus, and results are available within 2 working days after reception of the samples at our laboratories.

Speak with your physician to learn if the Combitest® screen is right for you, and available at your Procrea Fertility location.

Note: If the results from the Combitest® screen indicate a high risk, NIFTY® test*, Amniocentesis, CombiGene® test and genetic counseling are available at Procrea Fertility at no additional cost.

*The NIFTY® test is included without cost only if the “Combitest®/NIFTY® Reflex” option is chosen and the Combitest® screen result indicate high risk.Combitest® and CombiGene® are registered trademarks of GROUPE OPMEDIC INC. NIFTY® is a registered trademark of BGI.